Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Molecular identification of SARS-CoV-2 variants of concern at urban wastewater treatment plants across South Africa

View ORCID ProfileMukhlid Yousif, View ORCID ProfileSaid Rachida, View ORCID ProfileSetshaba Taukobong, View ORCID ProfileNkosenhle Ndlovu, View ORCID ProfileChinwe Iwu-Jaja, View ORCID ProfileWayne Howard, View ORCID ProfileShelina Moonsamy, Nompilo Mhlambi, View ORCID ProfileSipho Gwala, View ORCID ProfileJoshua I. Levy, Kristian G. Andersen, View ORCID ProfileCathrine Scheepers, View ORCID ProfileAnne von Gottberg, Nicole Wolter, Arshad Ismail, View ORCID ProfileMelinda Suchard, View ORCID ProfileKerrigan McCarthy, the SACCESS network
doi: https://doi.org/10.1101/2022.12.15.22283506
Mukhlid Yousif
1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
2Department of Virology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mukhlid Yousif
  • For correspondence: mukhlidy{at}nicd.ac.za Mukhlid.yousif{at}gmail.com
Said Rachida
1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Said Rachida
Setshaba Taukobong
1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Setshaba Taukobong
Nkosenhle Ndlovu
1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nkosenhle Ndlovu
Chinwe Iwu-Jaja
1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chinwe Iwu-Jaja
Wayne Howard
1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wayne Howard
Shelina Moonsamy
1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shelina Moonsamy
Nompilo Mhlambi
1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sipho Gwala
1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sipho Gwala
Joshua I. Levy
3Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua I. Levy
Kristian G. Andersen
3Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cathrine Scheepers
4SAMRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cathrine Scheepers
Anne von Gottberg
5Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
6School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne von Gottberg
Nicole Wolter
5Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
6School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arshad Ismail
7Sequencing Core Facility, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
8Department of Biochemistry and Microbiology, Faculty of Science, Engineering and Agriculture, University of Venda, Thohoyandou, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melinda Suchard
9Department of Chemical Pathology, School of Pathology, University of the Witwatersrand, Johannesburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Melinda Suchard
Kerrigan McCarthy
1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, South Africa
10School of Public Health, University of the Witwatersrand, Johannesburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kerrigan McCarthy
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The use of wastewater for SARS-CoV-2 surveillance is a useful complementary tool to clinical surveillance. The aims of this study were to characterize SARS-CoV-2 from wastewater samples, and to identify variants of concern present in samples collected from wastewater treatment plants in South African urban metros from April 2021 to January 2022. A total of 325 samples were collected from 15 wastewater treatment plants. Nucleic acids were extracted from concentrated samples, and subjected to amplicon-based whole genome sequencing. To identify variants of concerns and lineages, we used the Freyja tool (https://github.com/andersen-lab/Freyja), which assigns each sample with the prevalence of each variant present. We also used signature mutation analysis to identify variants in each wastewater treatment site. A heatmap was generated to identify patterns of emerging mutations in the spike gene using Excel conditional formatting. Using the Freyja tool, the Beta variant was detected and became predominate from April to June 2021 followed by the Delta variant and lastly the Omicron variant. Our heatmap approach was able to identify a pattern during the changes of predominate variant in wastewater with the emergence of mutations and the loss of others. In conclusion, sequencing of SARS-CoV-2 from wastewater largely corresponded with sequencing from clinical specimens. Our heatmap has the potential to detect new variants prior to emergence in clinical samples and this may be particularly useful during times of low disease incidence between waves, when few numbers of positive clinical samples are collected and submitted for testing. A limitation of wastewater sequencing is that it is not possible to identify new variants, as variants are classified based on known mutations in clinical strains.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the National Institute for Communicable Diseases (NICD) of South Africa, the Water Research Commission (WRC) of South Africa, the German Society for International Cooperation (GIZ) and Bill and Melinda Gates foundation (BMGF), and Africa CDC.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present work are contained in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 16, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Molecular identification of SARS-CoV-2 variants of concern at urban wastewater treatment plants across South Africa
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Molecular identification of SARS-CoV-2 variants of concern at urban wastewater treatment plants across South Africa
Mukhlid Yousif, Said Rachida, Setshaba Taukobong, Nkosenhle Ndlovu, Chinwe Iwu-Jaja, Wayne Howard, Shelina Moonsamy, Nompilo Mhlambi, Sipho Gwala, Joshua I. Levy, Kristian G. Andersen, Cathrine Scheepers, Anne von Gottberg, Nicole Wolter, Arshad Ismail, Melinda Suchard, Kerrigan McCarthy, the SACCESS network
medRxiv 2022.12.15.22283506; doi: https://doi.org/10.1101/2022.12.15.22283506
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Molecular identification of SARS-CoV-2 variants of concern at urban wastewater treatment plants across South Africa
Mukhlid Yousif, Said Rachida, Setshaba Taukobong, Nkosenhle Ndlovu, Chinwe Iwu-Jaja, Wayne Howard, Shelina Moonsamy, Nompilo Mhlambi, Sipho Gwala, Joshua I. Levy, Kristian G. Andersen, Cathrine Scheepers, Anne von Gottberg, Nicole Wolter, Arshad Ismail, Melinda Suchard, Kerrigan McCarthy, the SACCESS network
medRxiv 2022.12.15.22283506; doi: https://doi.org/10.1101/2022.12.15.22283506

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)